Dr méd. Didier Chardonnens

Spécialiste en gynécologie et obstétrique, membre FMH

Expérience professionnelle

2011–2013 Senior Consultant, Gyn. & Obst., University Hospital Geneva
2003–2004 Acting Head of Reproductive Medicine Service, Gyn. & Obst., University Hospital Geneva
2002–2003 Senior Consultant, Gyn. & Obst., University Hospital Geneva
1998–2002 Consultant, Gyn. & Obst., University Hospital Geneva
1995–1998 Senior Registrar, Gyn. & Obst., University Hospital Geneva
1994–1995 Junior Registrar, Endocrinology, University Hospital Geneva
1994 Research Fellow, Gyn. & Obst., Jessop Women Hospital Sheffield
1993–1994 Senior Registrar, Gyn. & Obst., Hospital Aigle
1993 Registrar, Gyn. & Obst., University Hospital Johannesburg
1990–1992 SHO, Gyn. & Obst., University Hospital Geneva
1989–1990 SHO, Gyn. & Obst., University Hospital Johannesburg
1987–1989 SHO, Endocrinology, University Hospital Geneva
1986–1987 SHO, Psychiatry, Hospital de Marsens
1985–1986 SHO, Surgery, Monthey Hospital


2002 Associate Professor (Privat Docent) Geneva University
2001 Reproductive Medicine Specialist Swiss Diploma
1994 Gynecology and Obstetrics Specialist Swiss Diploma
1992 MRCOG part I examination
1990 Medicine Doctorate
1985 Federal Diploma of Medicine


  • Société Suisse de Gynécologie et Obstétrique (SSGO)
  • British Fertility Society (BFS)
  • European Society of Human Reproduction and Embryology (ESHRE)
  • Société Suisse de Fertilité, Stérilité et de Planning Familial (SSFP)
  • North American Society of Menopause (NAMS)
  • European Society of Gynaecologic Endoscopy (ESGE)

Published in peer reviewed journals

  1. Vallotton MB, Capponi AM, Rossier MF, Johnson E, Chardonnens D & Lang U Cellules-cibles de I'angiotensine II et de la vasopressine: les "boîtes noires" révèlent leurs secrets. Bulletin et Mémoires de I'Académie Royale de Médecine de Belgique (1988), 143, 475-488. (pas répertorié)
  2. Chardonnens D, Lang U, Capponi AM & Vallotton MB Comparison of the effects of Angiotensin II and Vasopressin on cytosolic free calcium concentration, protein kinase C activity, and prostacyclin production in cultured rat aortic and mesenteric smooth muscle cells. Journal of Cardiovascular Pharmacology (1989), 14 ( Suppl 6), S39-S44.(1.553)
  3. Chardonnens D, Lang U, Rossier MF, Capponi AM & Vallotton MB Inhibitory and stimulatory effects of phorbol ester on vasopressin-induced cellular reponses in cultured rat aortic smooth muscle cells. Journal of Biology and Chemistry (1990), 265, 10451-10457.(7,666)
  4. Kem DC, Johnson E, Capponi AM, Chardonnens D, Lang U, Blondel B, Koshida H & Vallotton MB Effect of angiotensin II on cytosolic free calcium in neonatal rat cardiomyocytes. American Journal of Physiology (1991), 261, C77-C85. (3,276)
  5. Sakkas D, Shoukir Y, Chardonnens D, Bianchi PG & Campana A. Early cleavage of human embryos to the two cell stage after intra-cytoplasmic sperm injection as an indicator of embryo viability. Human Reproduction (1998), 13, 1, 182-187. (2,987)
  6. Shoukir Y, Chardonnens D, Campana A & Sakkas D. The rate of development and time of transfer play different roles in influencing the viability of human blastocysts. Human Reproduction (1998), 13, 3, 676 -681. (2,987)
  7. Shoukir Y, Chardonnens D, Campana A & Sakkas D. Blastocyst development from supernumerary embryos after intracytoplasmic sperm injection: a paternal influence ? Human Reproduction (1998), 13, 6, 1632-1637. (2,987)
  8. Mock P, Chardonnens D, Stamm P, Campana A & Bischof P. The apparent late half - life of human chorionic gonadotropin (HCG) after surgical treatment for ectopic pregnancy. A New approach to diagnose persistent trophoblastic activity. European Journal of Obtetrics and Gynaecology and Reproductive Biology (1998), 78, 99-102.(0,884)
  9. Mock P, Bischof P, Rivest R, Campana A & Chardonnens D. Modulation of hCG bioactivity during the first trimester of pregnancy. Human Reproduction (1998), 13, 9, 2629-2632. (2,987)
  10. Chardonnens D, Sylvan K, Walker D, Bischof P, Sakkas D & Campana A. Triptorelin administration in early pregnancy: Case reports and review of the literature. European Journal of Obtetrics and Gynaecology and Reproductive Biology (1998), 80, 143-149. .(0,884)
  11. Chardonnens D, Cameo P, Aubert M, Pralong FP, Campana A, Gaillard RC & Bischof P. Modulation of human cytotrophoblastic leptin secretion by interleukin-1 and 17-estradiol and its effect on human chorionic gonadotropin secretion . Molecular Human Reproduction, (1999) 5, 11, 1077-1082. (2.75)
  12. Meisser A, Chardonnens D, Campana A & Bischof P. Effects of tumor necrosis factor alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. Molecular Human Reproduction (1999), 5, 3, 252-260. (2.75)
  13. Morales M, Chardonnens D, A Bottani & A Campana. Syndrome du blépharophimosis-ptosis-epicanthus inversus et stérilité. Journal de Gynécologie Obstétrique et Biologie de la reproduction (1999), 28, 833-7. ()
  14. Paoloni-Giacobino A, Dahoun SP, Sizonenko PC, Stalberg A, Chardonnens D and Campana A. A case of 45,X Turner syndrome with ovulatory cycles. Gynaecology Endocrinology (2000), 14 , 105-110. (0,878)
  15. D Chardonnens, Islami D, Cameo P, Campana A and P Bischof. Trophoblastic leptin: regulation of its production and in vitro effects. Giornale Italiano di Ostetricia e Ginecologia (1999), 11, 532-535.( pas répertorié)
  16. RR Gonzales, C Simon, P Caballero-Campo, R Norman, D Chardonnens, L Devoto and P Bischof. Leptin and reproduction. Human Reproduction Update 2000, 6, 290-300. (2,969)
  17. D Islami, D Chardonnens, A Campana and P Bischof. Comparison of the effects of Gonadotrophin-Releasing Hormone GnRH I and II on human chorionic gonadotrophin (hCG) synthesis and secretion by first trimester trophoblast. Molecular Human Reproduction (2001), 7, 1, 3-9. (2.75)
  18. C de Vantery Arrighi, H Lucas, D El Mowafi, A Campana and D Chardonnens. Effect of human hydrosalpinx fluid on in vitro mouse fertilization and cleavage. Human Reproduction (2001), 16(4), 676-682. (2,987)
  19. D El Mowafi, U El Hendy, H Lucas H, D Chardonnens, C de Vanthéry and P Bischof Effect of hydrosalpynx fluid on implantation and blastocyst MMP-9 production. Egyptian Journal of Fertility and Sterility (2001) (pas répertorié)
  20. N Jastrow, P Bischof, M Araman, A Meisser, A Campana and D Chardonnens. Effect of hydrosalpynx fluid on trophoblastic matrix metalloproteinases secretion. Fertility and Sterility (2002), 77 (3), 588-594. (2,960)
  21. D Sakkas, G Leppens-Luisier, H Lucas, D Chardonnens, A Campana, DR Franken and F Urner. Localization of tyrosine phosphorylated proteins in human sperm and relation to capacitation and zona pellucida binding Biology of Reproduction (2003), 68(4), 1463-1469. (3,2)
  22. JM Ayoubi, M Epiney, D Chardonnens, PA Brioschi, R Fanchin, A Campana and D de Ziegler Comparison of changes in uterine contraction frequency after ovulation in the menstrual cycle and in vitro fertilization cycle. Fertility and Sterility (2003), 79 (5), 1101-1105. (2,960)
  23. F Bianchi de Micheli, R Kulier, H Lucas and D Chardonnens Premenstruel syndrome Swiss Medical Weekly (2002) (0.118)
  24. Possible interactions between leptin, gonadotrophin releasing hormone (GnRH) and human chorionic gonadotrophin (hCG). D Islami, D Chardonnens and P Bischof European Journal of Obtetrics and Gynaecology and Reproductive Biology (2003), 110 (2), 169-175. (0,878)
  25. D Islami, P Bischof and D Chardonnens Modulation of placental vascular endothelial growth factor by leptin and hCG. Molecular Human Reproduction (2003), 9 (7), 395-398.
  26. F Bianchi de Micheli, F Lüdicke and D Chardonnens Case report of an imaginary pregnancy in menopause Maturitas 2003
  27. Bianchi-Demicheli F, Perrin E, Dupanloup A, Dumont P, Bonnet J, Berthoud M, Kulier R, Bettoli L, Lorenzi-Cioldi F, Chardonnens D. Contraceptive counselling and social representations: a qualitative study. Swiss Med Wkly. (2006), 136(7-8):127-34.
  28. Removal of spermatozoa with externalized phosphatidylserine from sperm preparation in human assisted medical procreation: effects on viability, motility and mitochondrial membrane potential.l.de Vantéry Arrighi C, Lucas H, Chardonnens D, de Agostini Reprod Biol Endocrinol. 2009 Jan 8;7:1.

Published in non peered review journals

  1. Chardonnens D & Campana A. Effets de l’exercice physique sur le cycle mentruel. Rencontre Internationale Médico - Sportive : Médecine et Cyclisme (1996)
  2. Campana A & Chardonnens D. La contraception orale. Médecine et Hygiène (1998), 2205, 833-838.
  3. Chardonnens D & Campana A. Ovaires polykystiques : quand suspecter le diagnostic. Revue médicale de la Suisse romande (1999), 119, 459-461.
  4. Bianchi de Micheli F, H Lucas, D Medico & Chardonnens D. Aspects sexologiques en médecine de la reproduction Médecine et Hygiène (2003) in Press
  5. Chardonnens D. Prise en charge des aménorrhées secondaires Médecine et Hygiène Numéro spécial Quadrimed (2003), S25.

Book Chapters

  1. Lang U, Daniel C, Chardonnens D, Capponi AM & Vallotton MB Modulatory effects of protein kinase C activation in aortic smooth muscle and in adrenal glomerulosa cells during angiotensin II stimulation. In Methodological Surveys in Biochemistry and Medecine: Cell Signalling (1991), Vol 21, 115126 , Ed Reid E, Cook GMW & Luzio JP, Royal Society of Chemistry, Cambridge.
  2. Kinkel K & Chardonnens D. Endometriosis. In MRI and CT of the female pelvis (2007). Ed B Hamm R Forstner Springer Verlag Berlin Heidelberg New York
  • Prix de la Faculté de Médecine de Genève 1990 pour la thèse
  • Nominated for award of best paper presented XIth Washington International Spring Symposium, Washington DC 1991
  • Casmed BFS award for best poster at the joint British Fertility Society - British Andrology Society - Society for the Study of Fertility meeting, York 1997
  • SSGO Premier Prix des Posters Genève 1998
  • Nominated for the Fertility Society of Australia Price at the British Fertility Society meeting, Sheffield 1998
Portrait Dr méd. Didier Chardonnens


Clinique de Genolier
Route du Muids 3
1272 Genolier

T +41 22 366 97 32 F +41 22 366 90 39 meyrin@medixy.ch

Télécharger la vCard